Consistent with the glial nature of malignant gliomas, genes downregulated at T2 and End were enriched for neuronal differentiation and synaptic functions (e.g., DCX, NEUROD2, and SYN1) (Fig. 3d). This evidence concerns the gene NEUROD2 and malignant glioma.